No headlines found.
Adagio Medical Reports Third Quarter 2024 Results
Business Wire (Thu, 14-Nov 4:01 PM ET)
Adagio Medical to Present at the Stifel 2024 Healthcare Conference
Business Wire (Mon, 4-Nov 4:01 PM ET)
Business Wire (Thu, 24-Oct 8:30 AM ET)
Business Wire (Mon, 7-Oct 4:01 PM ET)
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
Adagio Medical Holdings trades on the NASDAQ stock market under the symbol ADGM.
As of December 13, 2024, ADGM stock price declined to $2.02 with 9,621 million shares trading.
ADGM has a beta of -0.31, meaning it tends to be less sensitive to market movements. ADGM has a correlation of 0.00 to the broad based SPY ETF.
ADGM has a market cap of $29.36 million. This is considered a Sub-Micro Cap stock.
ADGM support price is $1.91 and resistance is $2.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADGM shares will trade within this expected range on the day.